2010 Press Releases

  • Macrophages: The “Defense” Cells That Help Throughout the Body

    Released August 26, 2010 - Microphages are antimicrobial warriors and play critical roles in immune regulation and wound-healing. They can respond to a variety of cellular signals and change their physiology in response to local cues. This presentation focused on how macrophages exist in nearly all tissues and are produced when white blood cells called monocytes leave the blood and differentiate in a tissue-specific manner. Immune-regulating macrophages produce high levels of the cytokine interleukin-10, which helps suppress the body’s immune response and may hold the key to developing treatments for autoimmune diseases such as multiple sclerosis or rheumatoid arthritis.
  • Brown Rice and Cardiovascular Protection

    Released April 26, 2010 -- Brown rice might have an advantage over white rice by offering protection from high blood pressure and atherosclerosis (“hardening of the arteries”), say researchers at Temple University School of Medicine in Philadelphia. New research suggests that a component in a layer of tissue surrounding grains of brown rice may work against angiotensin II, an endocrine protein and a known culprit in the development of high blood pressure and atherosclerosis.
  • Predicting Risk for High Blood Pressure

    Released April 26, 2010 -- There are racial differences in the activity of enzymes that make or break down a major regulator of blood pressure. New research results correlate with the bias of African Americans being more at risk for hypertension. The findings were that African American boys have more of the enzyme that makes the hormone that contributes to high blood pressure and African American girls have less of the enzyme that makes the hormone that protects against high blood pressure or hypertension.
  • SSRIs and Cardiovascular Health

    Released April 26, 2010 -- A class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) may provide a boost to cardiovascular health by affecting the way platelets, small cells in the blood involved in clotting, clump together. A research team found that depressed patients who have an associated risk of cardiovascular problems, the blocking activity of SSRIs may have a side-effect of preventing the serotonin uptake by platelets, making them less responsive to aggregation and may thereby improving the patients’ cardiovascular health.